Impact of B18R-Encoding Messenger Ribonucleic Acid Co-Delivery on Neutralizing Antibody Production in Self-Amplifying Messenger Ribonucleic Acid Vaccines.

Saved in:
Bibliographic Details
Title: Impact of B18R-Encoding Messenger Ribonucleic Acid Co-Delivery on Neutralizing Antibody Production in Self-Amplifying Messenger Ribonucleic Acid Vaccines.
Authors: Wang Y; 302 Clinical Medical School, Peking University, Beijing 100039, China.; Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China., Li L; Center for Synthetic and Systems Biology, Department of Automation, Tsinghua University, Beijing 100084, China., Liang M; Beijing Syngenbio Co., Ltd., Beijing 100176, China.; Syngen-Bioimmune (Qing Dao) Co., Ltd., Qingdao 266000, China., Liu G; Syngen-Bioimmune (Qing Dao) Co., Ltd., Qingdao 266000, China.; Beijing Syngentech Co., Ltd., Beijing 100176, China.; Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China., Lu Y; 302 Clinical Medical School, Peking University, Beijing 100039, China.; Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China.; Comprehensive Liver Cancer Centre, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
Source: Vaccines [Vaccines (Basel)] 2025 May 18; Vol. 13 (5). Date of Electronic Publication: 2025 May 18.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first